发明人张德明,郑宇鹏,孙丽萍. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 110039636 A, 授权公告日 2016-02-21.
Björnsson E, Nielsen H, Mueller T C. "Method for the Synthesis of 34425-22-4
UBJ4311737
Pelargonidin 3-galactoside
UNII-UBJ4311737
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride (1:1)
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride
Flavylium, 3-(galactosyloxy)-4',5,7-trihydroxy-, chloride
Pelargonidin, 3-galactoside
3-(Galactosyloxy)-4',5,7-trihydroxyflavylium chloride" [P]. European Patent, EP 3362592 A1, 2025-11-12.
Park J H, Stevens L M, Mueller T. "A Process for Preparing High-Purity 34425-22-4
UBJ4311737
Pelargonidin 3-galactoside
UNII-UBJ4311737
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride (1:1)
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride
Flavylium, 3-(galactosyloxy)-4',5,7-trihydroxy-, chloride
Pelargonidin, 3-galactoside
3-(Galactosyloxy)-4',5,7-trihydroxyflavylium chloride" [P]. US Patent, US 10226134 B2, 2022-02-26.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2012, 2446, 3593-3623.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2016, 2426, (12), 389-397.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 34425-22-4
UBJ4311737
Pelargonidin 3-galactoside
UNII-UBJ4311737
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride (1:1)
1-Benzopyrylium, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride
Flavylium, 3-(galactosyloxy)-4',5,7-trihydroxy-, chloride
Pelargonidin, 3-galactoside
3-(Galactosyloxy)-4',5,7-trihydroxyflavylium chloride Using HRMS and NMR". Environ. Sci. Technol., 2019, 211, (1), 8073-8080.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2020, 694, (3), 2243-2250.